Recurrent ischemic stroke: Incidence, predictors, and impact on mortality
- PMID: 30929256
- PMCID: PMC6594196
- DOI: 10.1111/ane.13093
Recurrent ischemic stroke: Incidence, predictors, and impact on mortality
Abstract
Background and purpose: Recurrent ischemic stroke (IS) or TIA is frequent with a considerable variation in incidence and mortality across populations. Current data on stroke recurrence and mortality are useful to examine trends, risk factors, and treatment effects. In this study, we calculated the incidence of recurrent IS or TIA in a hospital-based stroke population in Western Norway, investigated recurrence factors, and estimated the effect of recurrence on all-cause mortality.
Methods: This prospective cohort study registered recurrence and mortality among 1872 IS and TIA survivors admitted to the stroke unit at Haukeland University Hospital between July 2007 and December 2013. Recurrence and death until September 1, 2016, were identified by medical chart review. Cumulative incidences of recurrence were estimated with a competing risks Cox model. Multivariate Cox models were used to examine recurrence factors and mortality.
Results: During follow-up, 220 patients had 277 recurrent IS or TIAs. The cumulative recurrence rate was 5.4% at 1 year, 11.3% at 5 years, and 14.2% at the end of follow-up. Hypertension (HR = 1.65, 95% CI 1.21-2.25), prior symptomatic stroke (HR = 1.63, 95% CI 1.18-2.24), chronic infarcts on MRI (HR = 1.48, 95% CI 1.10-1.99), and age (HR 1.02/year, 95% CI 1.00-1.03) were independently associated with recurrence. A total of 668 (35.7%) patients died during follow-up. Recurrence significantly increased the all-cause mortality (HR = 2.55, 95% CI 2.04-3.18).
Conclusions: The risk of recurrent IS stroke or TIA was modest in our population and was associated with previously established risk factors. Recurrence more than doubled the all-cause mortality.
Keywords: cerebrovascular disease; neuroepidemiology; stroke etiology; stroke recurrence.
© 2019 The Authors. Acta Neurologica Scandinavica Published by John Wiley & Sons Ltd.
Conflict of interest statement
None.
Figures
Comment in
-
Comment on "Recurrent ischemic stroke: Incidence, predictors, and impact on"….Acta Neurol Scand. 2020 Mar;141(3):259. doi: 10.1111/ane.13168. Epub 2019 Oct 4. Acta Neurol Scand. 2020. PMID: 31529469 No abstract available.
-
Factors of recurrence in patients with ischemic stroke or TIA.Acta Neurol Scand. 2020 Mar;141(3):258. doi: 10.1111/ane.13178. Epub 2019 Oct 23. Acta Neurol Scand. 2020. PMID: 31600822 No abstract available.
References
-
- Feigin VL, Lawes CM, Bennett DA, Barker‐Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population‐based studies: a systematic review. Lancet Neurol. 2009;8(4):355‐369. - PubMed
-
- Bergstrom L, Irewall AL, Soderstrom L, Ogren J, Laurell K, Mooe T. One‐year incidence, time trends, and predictors of recurrent ischemic stroke in Sweden from 1998 to 2010: an observational study. Stroke. 2017;48(8):2046‐2051. - PubMed
-
- Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky‐Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta‐analysis. Stroke. 2011;42(5):1489‐1494. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
